1
|
Abboud CS, Brandão EHDS, Cunha KRL, de Sousa Brito K, Gallo CDB, Molon AC, Horliana ACRT, Franco ASL, Thongprasom K, Rodrigues MFSD. Serum and salivary cytokines in patients with oral lichen planus treated with Photobiomodulation. Oral Dis 2023; 29:1250-1258. [PMID: 34817126 DOI: 10.1111/odi.14084] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2021] [Revised: 10/15/2021] [Accepted: 11/08/2021] [Indexed: 01/22/2023]
Abstract
OBJECTIVES To evaluate the serum and salivary levels of IL-1β, IL-6, IL-17A, TNF-α, IL-4, and IL-10 in patients with oral lichen planus (OLP) treated with Photobiomodulation (PBM) and clobetasol propionate 0.05%. MATERIAL AND METHODS Thirty-four OLP patients were randomized into two groups: Control (clobetasol propionate 0.05%) and PBM (660 nm, 100 mW, 177 J/cm2 , 5 s, 0.5 J per point). Serum and saliva were collected at baseline and at the end of treatment (after 30 days) and evaluated using ELISA. The cytokine results were correlated with pain, clinical subtypes, and clinical scores of OLP. RESULTS IL-1β, IL-6, IL-17A, TNF-α, and IL-4 levels were higher in saliva in relation to serum. IL-1β was the most concentrated cytokine in saliva, and a positive correlation with the severity of OLP was noticed. After treatment with corticosteroid, IL-1β in saliva decreased significantly. No modulation of all cytokines was observed after PBM. CONCLUSION IL-1β appears to be an important cytokine involved in OLP pathogenesis. In addition, the mechanisms of action of PBM do not seem to be linked to the modulation of pro or anti-inflammatory cytokines at the end of treatment. It is possible that this events occurred early during treatment.
Collapse
Affiliation(s)
- Clery Saad Abboud
- Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil
| | | | - Karen Roberta Lopes Cunha
- Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil
| | - Kaline de Sousa Brito
- Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil
| | - Camila de Barros Gallo
- Department of Stomatology, School of Dentistry, University of São Paulo, São Paulo, Brazil
| | - Angela Cristina Molon
- Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil
| | | | - Adriana Santos Lino Franco
- Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil
| | - Kobkan Thongprasom
- Oral Medicine Department, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand
| | | |
Collapse
|
2
|
Sobral SS, da Silva Brandão EH, de Barros Gallo C, Molon A, Sobral APT, de Fátima Teixeira da Silva D, Motta LJ, Dos Santos Franco AL, Rodrigues MFSD. Analysis of the psychopathological profile, quality of life, and cost-effectiveness of oral lichen planus patients treated with photobiomodulation. Clin Oral Investig 2021; 26:719-728. [PMID: 34251533 DOI: 10.1007/s00784-021-04050-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2021] [Accepted: 06/22/2021] [Indexed: 10/20/2022]
Abstract
OBJECTIVES To evaluate the effect of PBM on the psychological profile and quality of life of patients with oral lichen planus (OLP) in comparison to corticoid and to investigate the cost-effectiveness of both treatments. MATERIALS AND METHODS Patients were randomized into two groups: Control (clobetasol propionate 0.05%) and Photobiomodulation (660 nm, 100mW, 177 J/cm2, 5 s, 0.5 J) twice a week for 30 days. The Hospital Anxiety and Depression Scale (HADS) and OHIP-14 were used in different treatment time points and at follow-up. The cost-effectiveness was calculated using the improvement in OHIP-14 after treatment. RESULTS OLP patients showed detected levels of anxiety, depression, and poor quality of life at baseline. No improvement in anxiety and depression was noticed after treatments. However, PBM and corticoid significantly improved the quality of life of OLP patients, considering the OHIP-14-T and the physical pain domain. The treatment with corticoid was more cost-effective than PBM. CONCLUSIONS Psychological distress was not improved after both treatments and PBM is as effective as corticoids in promoting a better quality of life in OLP patients, despite its higher cost. CLINICAL RELEVANCE This study highlights the need for additional therapeutic interventions in OLP patients, to early recognize and to manage the alterations in their psychological profile. Moreover, PBM is an effective therapy in OLP patient's quality of live and although it was a more expensive, the advantage of being a minimally invasive therapy associated with no side effects must be considered in clinical practice, especially in those patients with refractory disease. TRIAL REGISTRATION This study is registered at ClinicalTrials.gov; the registration number is NCT03320460, registered in 17/10/2017.
Collapse
Affiliation(s)
- Sérgio Sousa Sobral
- Postgraduate Program in Biophotonics Applied To Health Sciences, Nove de Julho University, UNINOVE, R. Vergueiro, 235/249, São Paulo, CEP 01504-001, Brazil
| | - Eloíza Helena da Silva Brandão
- Postgraduate Program in Biophotonics Applied To Health Sciences, Nove de Julho University, UNINOVE, R. Vergueiro, 235/249, São Paulo, CEP 01504-001, Brazil
| | - Camila de Barros Gallo
- Department of Stomatology, School of Dentistry, University of São Paulo, São Paulo, Brazil
| | - Angela Molon
- Postgraduate Program in Biophotonics Applied To Health Sciences, Nove de Julho University, UNINOVE, R. Vergueiro, 235/249, São Paulo, CEP 01504-001, Brazil
| | - Ana Paula Taboada Sobral
- Postgraduate Program in Biophotonics Applied To Health Sciences, Nove de Julho University, UNINOVE, R. Vergueiro, 235/249, São Paulo, CEP 01504-001, Brazil.,Postgraduate Program in Health and Environment, Universidade Metropolitana de Santos (UNIMES), Santos, Brazil
| | - Daniela de Fátima Teixeira da Silva
- Postgraduate Program in Biophotonics Applied To Health Sciences, Nove de Julho University, UNINOVE, R. Vergueiro, 235/249, São Paulo, CEP 01504-001, Brazil
| | - Lara Jansiski Motta
- Postgraduate Program in Biophotonics Applied To Health Sciences, Nove de Julho University, UNINOVE, R. Vergueiro, 235/249, São Paulo, CEP 01504-001, Brazil
| | - Adriana Lino Dos Santos Franco
- Postgraduate Program in Biophotonics Applied To Health Sciences, Nove de Julho University, UNINOVE, R. Vergueiro, 235/249, São Paulo, CEP 01504-001, Brazil
| | - Maria Fernanda Setúbal Destro Rodrigues
- Postgraduate Program in Biophotonics Applied To Health Sciences, Nove de Julho University, UNINOVE, R. Vergueiro, 235/249, São Paulo, CEP 01504-001, Brazil.
| |
Collapse
|